Citigroup’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.35K Buy
913
+224
+33% +$1.56K ﹤0.01% 4509
2025
Q1
$5.85K Buy
689
+59
+9% +$501 ﹤0.01% 4481
2024
Q4
$8.82K Sell
630
-38
-6% -$532 ﹤0.01% 4544
2024
Q3
$15.1K Sell
668
-94
-12% -$2.13K ﹤0.01% 4437
2024
Q2
$15.4K Buy
762
+634
+495% +$12.8K ﹤0.01% 4318
2024
Q1
$3.19K Sell
128
-15,500
-99% -$386K ﹤0.01% 4581
2023
Q4
$283K Buy
15,628
+15,096
+2,838% +$273K ﹤0.01% 3025
2023
Q3
$10.7K Sell
532
-71
-12% -$1.43K ﹤0.01% 3816
2023
Q2
$15.4K Buy
603
+148
+33% +$3.78K ﹤0.01% 4318
2023
Q1
$9.68K Sell
455
-56
-11% -$1.19K ﹤0.01% 4081
2022
Q4
$15.1K Sell
511
-23
-4% -$681 ﹤0.01% 4003
2022
Q3
$12K Sell
534
-55
-9% -$1.24K ﹤0.01% 4187
2022
Q2
$10K Sell
589
-159
-21% -$2.7K ﹤0.01% 4617
2022
Q1
$33K Sell
748
-54
-7% -$2.38K ﹤0.01% 4192
2021
Q4
$49K Buy
802
+649
+424% +$39.7K ﹤0.01% 4303
2021
Q3
$6K Sell
153
-913
-86% -$35.8K ﹤0.01% 4803
2021
Q2
$32K Buy
1,066
+553
+108% +$16.6K ﹤0.01% 4364
2021
Q1
$15K Buy
+513
New +$15K ﹤0.01% 4729